Diagnostic capabilities, clinical features, and longitudinal <scp><i>UBA1</i></scp> clonal dynamics of a nationwide <scp>VEXAS</scp> cohortCarmelo Gurnari, Maria Teresa Voso, Giorgia Battipaglia et al.|American Journal of Hematology|2023Cited by 43
Mechanisms of hematopoietic clonal dominance in VEXAS syndromeRaffaella Molteni, Samuele Ferrari, Corrado Campochiaro et al.|Nature Medicine|2025Cited by 38
Improving benefit-harm assessment of glucocorticoid therapy incorporating the patient perspective: The OMERACT glucocorticoid core domain setJoanna Tieu, Catherine Hill, Jonathan TL. Cheah et al.|Seminars in Arthritis and Rheumatism|2021Cited by 12
Methodology and clinical utility of longitudinal <scp><i>UBA1</i></scp> tracking in <scp>VEXAS</scp> syndromeCarmelo Gurnari, Maria Teresa Voso, Elisa Galossi et al.|British Journal of Haematology|2024Cited by 10
Clonal hematopoiesis meets an autoinflammatory disease: the new paradigm of VEXAS syndromeMartina Fiumara, Corrado Campochiaro, Raffaella Molteni et al.|Expert Review of Hematology|2025Cited by 3